false 2023-11-14 0001617765 00-0000000 Salona Global Medical Device Corp. 0001617765 2023-11-14 2023-11-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 14, 2023

SALONA GLOBAL MEDICAL DEVICE CORP.
(Exact name of registrant as specified in its charter)

British Columbia 333-255642 Not Applicable
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

49 Natcon Dr
 Shirley, New York, United States 11967
 (Address of principal executive offices) (ZIP Code)

Registrant’s telephone number, including area code: (800) 760-6826

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On November 14, 2023, Salona Global Medical Device Corporation (the "Company") issued a press release announcing its attendance at the Medica 2023 annual conference to be held in Dusseldorf, Germany from November 13, 2023 through November 16, 2023, which press release was filed via the Canadian Securities Administrators' System for Electronic Document Analysis and Retrieval (SEDAR). The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01.    Financial Statements and Exhibits.

(d)    Exhibits.

Exhibit No Description


99.1 Press Release of Salona Global Medical Device Corporation dated November 14, 2023.
104
 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

  SALONA GLOBAL MEDICAL DEVICE CORPORATION
 

     
Date:  November 14, 2023 By:  /s/ Natalia Vakhitova
  Name: Natalia Vakhitova
  Title: Chief Financial Officer

 

EXHIBIT 99.1

Salona Global Showcases Biodex Products at Medica Trade Fair in Düsseldorf, Germany;

Expanding Access to International Markets

New York, New York, November 14, 2023 - Salona Global Medical Device Corporation (the ‎‎‎"Company") (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., announced its attendance at Medica 2023 which is held annually in Dusseldorf, Germany. Being one of the premier events in the medical industry around the globe it allows the Company to showcase its products to the industry professionals and connect with potential customers and distributors/strategic partners abroad. CEO Mike Seckler will host a series of events and meetings with the aim of increasing access to untapped international markets for the Company's Biodex Rehab line of medical devices and its Mio-Guard line of medical and athletic supplies.

The Company's Biodex Rehab and Mio-Guard divisions are moving forward with collaborating in providing comprehensive services to physical therapy and sports rehabilitation clinics. While Biodex Rehab continues its focus on delivering science-based solutions for rehabilitation exercise and injury recovery segment, Mio-Guard serves as a reliable supplier of sports medicine supplies. Together, they will excel in offering an integrated approach to support the diverse needs of clinics in the field of Physical Medicine.

"Continuing with our accomplishment in the Polish marketplace, I have made international sales our priority. We have a stellar brand name coupled with a unique product lineup that I believe holds significant appeal for international markets were we have not previously excelled in contribution of marketing efforts. A major part of our revenue growth plan for 2024, especially in the first half of the year is expected to come from international markets that are in need of our devices. Finding and securing qualified distributors/strategic partners and new customers during our attendance of the world's leading trade show is the key to executing on this plan."

For more information please contact:‎

Mike Seckler ‎

Chief Executive Officer ‎

Tel: 1 (800) 760-6826 ‎

Email: Info@Salonaglobal.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the ‎policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this ‎release.‎

v3.23.3
Document and Entity Information Document
Nov. 14, 2023
Document Information [Line Items]  
Document Type 8-K
Document Creation Date Nov. 14, 2023
Document Period End Date Nov. 14, 2023
Amendment Flag false
Entity Registrant Name Salona Global Medical Device Corp.
Entity Address, Address Line One 49 Natcon Dr
Entity Address, City or Town Shirley
Entity Address, State or Province NY
Entity Address, Country US
Entity Address, Postal Zip Code 11967
Entity Incorporation, State Country Name A1
City Area Code 800
Local Phone Number 760-6826
Entity File Number 333-255642
Entity Central Index Key 0001617765
Entity Emerging Growth Company true
Entity Tax Identification Number 00-0000000
Entity Ex Transition Period false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Evome Medical Technologies (PK) (USOTC:LNDZF)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Evome Medical Technologies (PK) Charts.
Evome Medical Technologies (PK) (USOTC:LNDZF)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Evome Medical Technologies (PK) Charts.